Deb Lium

Deb Lium has extensive experience in clinical operations, currently serving as Vice President Global Head of Clinical Operations at Angitia Biopharmaceuticals from June 2022 to April 2024, following a prominent tenure at Amgen from September 1999 to June 2022, where Lium held roles as Director of Global Clinical Program Management and Clinical Research Program Manager. Lium earned a PhD in Exercise Physiology/Statistics from The University of New Mexico between January 1992 and January 1995.